The Market Reports

Index

1 Biopharma Buffer Market Overview
1.1 Product Overview and Scope of Biopharma Buffer
1.2 Biopharma Buffer Segment by Type
1.2.1 Global Biopharma Buffer Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Phosphates Type
1.2.3 Acetates Type
1.2.4 TRIS Type
1.2.5 Others
1.3 Biopharma Buffer Segment by Application
1.3.1 Biopharma Buffer Sales Comparison by Application: (2021-2027)
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Global Biopharma Buffer Market Size Estimates and Forecasts
1.4.1 Global Biopharma Buffer Revenue 2016-2027
1.4.2 Global Biopharma Buffer Sales 2016-2027
1.4.3 Biopharma Buffer Market Size by Region: 2016 Versus 2021 Versus 2027

2 Biopharma Buffer Market Competition by Manufacturers
2.1 Global Biopharma Buffer Sales Market Share by Manufacturers (2016-2021)
2.2 Global Biopharma Buffer Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Biopharma Buffer Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Biopharma Buffer Manufacturing Sites, Area Served, Product Type
2.5 Biopharma Buffer Market Competitive Situation and Trends
2.5.1 Biopharma Buffer Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biopharma Buffer Players Market Share by Revenue
2.5.3 Global Biopharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Biopharma Buffer Retrospective Market Scenario by Region
3.1 Global Biopharma Buffer Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Biopharma Buffer Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Biopharma Buffer Market Facts & Figures by Country
3.3.1 North America Biopharma Buffer Sales by Country
3.3.2 North America Biopharma Buffer Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biopharma Buffer Market Facts & Figures by Country
3.4.1 Europe Biopharma Buffer Sales by Country
3.4.2 Europe Biopharma Buffer Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biopharma Buffer Market Facts & Figures by Region
3.5.1 Asia Pacific Biopharma Buffer Sales by Region
3.5.2 Asia Pacific Biopharma Buffer Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biopharma Buffer Market Facts & Figures by Country
3.6.1 Latin America Biopharma Buffer Sales by Country
3.6.2 Latin America Biopharma Buffer Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biopharma Buffer Market Facts & Figures by Country
3.7.1 Middle East and Africa Biopharma Buffer Sales by Country
3.7.2 Middle East and Africa Biopharma Buffer Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Biopharma Buffer Historic Market Analysis by Type
4.1 Global Biopharma Buffer Sales Market Share by Type (2016-2021)
4.2 Global Biopharma Buffer Revenue Market Share by Type (2016-2021)
4.3 Global Biopharma Buffer Price by Type (2016-2021)

5 Global Biopharma Buffer Historic Market Analysis by Application
5.1 Global Biopharma Buffer Sales Market Share by Application (2016-2021)
5.2 Global Biopharma Buffer Revenue Market Share by Application (2016-2021)
5.3 Global Biopharma Buffer Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Avantor
6.1.1 Avantor Corporation Information
6.1.2 Avantor Description and Business Overview
6.1.3 Avantor Biopharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Avantor Product Portfolio
6.1.5 Avantor Recent Developments/Updates
6.2 Alfa Aesar (Thermo Fisher)
6.2.1 Alfa Aesar (Thermo Fisher) Corporation Information
6.2.2 Alfa Aesar (Thermo Fisher) Description and Business Overview
6.2.3 Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Alfa Aesar (Thermo Fisher) Product Portfolio
6.2.5 Alfa Aesar (Thermo Fisher) Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Biopharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Lonza
6.4.1 Lonza Corporation Information
6.4.2 Lonza Description and Business Overview
6.4.3 Lonza Biopharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lonza Product Portfolio
6.4.5 Lonza Recent Developments/Updates
6.5 Bio-Rad
6.5.1 Bio-Rad Corporation Information
6.5.2 Bio-Rad Description and Business Overview
6.5.3 Bio-Rad Biopharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bio-Rad Product Portfolio
6.5.5 Bio-Rad Recent Developments/Updates
6.6 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Biopharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.6.4 BD Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 GE Healthcare
6.6.1 GE Healthcare Corporation Information
6.6.2 GE Healthcare Description and Business Overview
6.6.3 GE Healthcare Biopharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GE Healthcare Product Portfolio
6.7.5 GE Healthcare Recent Developments/Updates
6.8 Promega Corporation
6.8.1 Promega Corporation Corporation Information
6.8.2 Promega Corporation Description and Business Overview
6.8.3 Promega Corporation Biopharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Promega Corporation Product Portfolio
6.8.5 Promega Corporation Recent Developments/Updates
6.9 Hamilton Company
6.9.1 Hamilton Company Corporation Information
6.9.2 Hamilton Company Description and Business Overview
6.9.3 Hamilton Company Biopharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Hamilton Company Product Portfolio
6.9.5 Hamilton Company Recent Developments/Updates
6.10 XZL BIO-TECHNOLOGY
6.10.1 XZL BIO-TECHNOLOGY Corporation Information
6.10.2 XZL BIO-TECHNOLOGY Description and Business Overview
6.10.3 XZL BIO-TECHNOLOGY Biopharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.10.4 XZL BIO-TECHNOLOGY Product Portfolio
6.10.5 XZL BIO-TECHNOLOGY Recent Developments/Updates
6.11 SRL
6.11.1 SRL Corporation Information
6.11.2 SRL Biopharma Buffer Description and Business Overview
6.11.3 SRL Biopharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.11.4 SRL Product Portfolio
6.11.5 SRL Recent Developments/Updates

7 Biopharma Buffer Manufacturing Cost Analysis
7.1 Biopharma Buffer Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biopharma Buffer
7.4 Biopharma Buffer Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biopharma Buffer Distributors List
8.3 Biopharma Buffer Customers

9 Biopharma Buffer Market Dynamics
9.1 Biopharma Buffer Industry Trends
9.2 Biopharma Buffer Growth Drivers
9.3 Biopharma Buffer Market Challenges
9.4 Biopharma Buffer Market Restraints

10 Global Market Forecast
10.1 Biopharma Buffer Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biopharma Buffer by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Biopharma Buffer by Type (2022-2027)
10.2 Biopharma Buffer Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biopharma Buffer by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Biopharma Buffer by Application (2022-2027)
10.3 Biopharma Buffer Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biopharma Buffer by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Biopharma Buffer by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Biopharma Buffer Sales (KL) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Biopharma Buffer Sales (KL) Comparison by Application (2021-2027)
Table 3. Global Biopharma Buffer Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Biopharma Buffer Covered in This Study
Table 5. Global Biopharma Buffer Sales (KL) of Key Manufacturers (2016-2021)
Table 6. Global Biopharma Buffer Sales Share by Manufacturers (2016-2021)
Table 7. Global Biopharma Buffer Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Biopharma Buffer Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Biopharma Buffer Average Price (US$/L) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Biopharma Buffer Manufacturing Sites and Area Served
Table 11. Manufacturers Biopharma Buffer Product Type
Table 12. Global Biopharma Buffer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biopharma Buffer by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharma Buffer as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biopharma Buffer Sales by Region (2016-2021) & (KL)
Table 16. Global Biopharma Buffer Sales Market Share by Region (2016-2021)
Table 17. Global Biopharma Buffer Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Biopharma Buffer Sales by Country (2016-2021) & (KL)
Table 19. North America Biopharma Buffer Sales Market Share by Country (2016-2021)
Table 20. North America Biopharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Biopharma Buffer Revenue Market Share by Country (2016-2021)
Table 22. Europe Biopharma Buffer Sales by Country (2016-2021) & (KL)
Table 23. Europe Biopharma Buffer Sales Market Share by Country (2016-2021)
Table 24. Europe Biopharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Biopharma Buffer Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Biopharma Buffer Sales by Region (2016-2021) & (KL)
Table 27. Asia Pacific Biopharma Buffer Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Biopharma Buffer Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Biopharma Buffer Revenue Market Share by Region (2016-2021)
Table 30. Latin America Biopharma Buffer Sales by Country (2016-2021) & (KL)
Table 31. Latin America Biopharma Buffer Sales Market Share by Country (2016-2021)
Table 32. Latin America Biopharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Biopharma Buffer Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Biopharma Buffer Sales by Country (2016-2021) & (KL)
Table 35. Middle East and Africa Biopharma Buffer Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Biopharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Biopharma Buffer Revenue Market Share by Country (2016-2021)
Table 38. Global Biopharma Buffer Sales (KL) by Type (2016-2021)
Table 39. Global Biopharma Buffer Sales Market Share by Type (2016-2021)
Table 40. Global Biopharma Buffer Revenue (Million US$) by Type (2016-2021)
Table 41. Global Biopharma Buffer Revenue Share by Type (2016-2021)
Table 42. Global Biopharma Buffer Price (US$/L) by Type (2016-2021)
Table 43. Global Biopharma Buffer Sales (KL) by Application (2016-2021)
Table 44. Global Biopharma Buffer Sales Market Share by Application (2016-2021)
Table 45. Global Biopharma Buffer Revenue (Million US$) by Application (2016-2021)
Table 46. Global Biopharma Buffer Revenue Share by Application (2016-2021)
Table 47. Global Biopharma Buffer Price (US$/L) by Application (2016-2021)
Table 48. Avantor Corporation Information
Table 49. Avantor Description and Business Overview
Table 50. Avantor Biopharma Buffer Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 51. Avantor Biopharma Buffer Product
Table 52. Avantor Recent Developments/Updates
Table 53. Alfa Aesar (Thermo Fisher) Corporation Information
Table 54. Alfa Aesar (Thermo Fisher) Description and Business Overview
Table 55. Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 56. Alfa Aesar (Thermo Fisher) Biopharma Buffer Product
Table 57. Alfa Aesar (Thermo Fisher) Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck Biopharma Buffer Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 61. Merck Biopharma Buffer Product
Table 62. Merck Recent Developments/Updates
Table 63. Lonza Corporation Information
Table 64. Lonza Description and Business Overview
Table 65. Lonza Biopharma Buffer Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 66. Lonza Biopharma Buffer Product
Table 67. Lonza Recent Developments/Updates
Table 68. Bio-Rad Corporation Information
Table 69. Bio-Rad Description and Business Overview
Table 70. Bio-Rad Biopharma Buffer Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 71. Bio-Rad Biopharma Buffer Product
Table 72. Bio-Rad Recent Developments/Updates
Table 73. BD Corporation Information
Table 74. BD Description and Business Overview
Table 75. BD Biopharma Buffer Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 76. BD Biopharma Buffer Product
Table 77. BD Recent Developments/Updates
Table 78. GE Healthcare Corporation Information
Table 79. GE Healthcare Description and Business Overview
Table 80. GE Healthcare Biopharma Buffer Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 81. GE Healthcare Biopharma Buffer Product
Table 82. GE Healthcare Recent Developments/Updates
Table 83. Promega Corporation Corporation Information
Table 84. Promega Corporation Description and Business Overview
Table 85. Promega Corporation Biopharma Buffer Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 86. Promega Corporation Biopharma Buffer Product
Table 87. Promega Corporation Recent Developments/Updates
Table 88. Hamilton Company Corporation Information
Table 89. Hamilton Company Description and Business Overview
Table 90. Hamilton Company Biopharma Buffer Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 91. Hamilton Company Biopharma Buffer Product
Table 92. Hamilton Company Recent Developments/Updates
Table 93. XZL BIO-TECHNOLOGY Corporation Information
Table 94. XZL BIO-TECHNOLOGY Description and Business Overview
Table 95. XZL BIO-TECHNOLOGY Biopharma Buffer Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 96. XZL BIO-TECHNOLOGY Biopharma Buffer Product
Table 97. XZL BIO-TECHNOLOGY Recent Developments/Updates
Table 98. SRL Corporation Information
Table 99. SRL Description and Business Overview
Table 100. SRL Biopharma Buffer Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 101. SRL Biopharma Buffer Product
Table 102. SRL Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Biopharma Buffer Distributors List
Table 106. Biopharma Buffer Customers List
Table 107. Biopharma Buffer Market Trends
Table 108. Biopharma Buffer Growth Drivers
Table 109. Biopharma Buffer Market Restraints
Table 110. Global Biopharma Buffer Sales Forecast by Type (2022-2027) & (KL)
Table 111. Global Biopharma Buffer Sales Market Share Forecast by Type (2022-2027)
Table 112. Global Biopharma Buffer Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 113. Global Biopharma Buffer Revenue Market Share Forecast by Type (2022-2027)
Table 114. Global Biopharma Buffer Sales Forecast by Application (2022-2027) & (KL)
Table 115. Global Biopharma Buffer Sales Market Share Forecast by Application (2022-2027)
Table 116. Global Biopharma Buffer Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 117. Global Biopharma Buffer Revenue Market Share Forecast by Application (2022-2027)
Table 118. Global Biopharma Buffer Sales Forecast by Region (2022-2027) & (KL)
Table 119. Global Biopharma Buffer Sales Market Share Forecast by Region (2022-2027)
Table 120. Global Biopharma Buffer Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 121. Global Biopharma Buffer Revenue Market Share Forecast by Region (2022-2027)
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biopharma Buffer
Figure 2. Global Biopharma Buffer Market Share by Type in 2020 & 2027
Figure 3. Phosphates Type Product Picture
Figure 4. Acetates Type Product Picture
Figure 5. TRIS Type Product Picture
Figure 6. Others Product Picture
Figure 7. Global Biopharma Buffer Market Share by Application in 2020 & 2027
Figure 8. Research Institution
Figure 9. Pharmaceutical Industry
Figure 10. Others
Figure 11. Global Biopharma Buffer Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Biopharma Buffer Market Size 2016-2027 (US$ Million)
Figure 13. Global Biopharma Buffer Sales 2016-2027 (KL)
Figure 14. Global Biopharma Buffer Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Biopharma Buffer Sales Share by Manufacturers in 2020
Figure 16. Global Biopharma Buffer Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Biopharma Buffer Players: Market Share by Revenue in 2020
Figure 18. Biopharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Biopharma Buffer Sales Market Share by Region (2016-2021)
Figure 20. Global Biopharma Buffer Sales Market Share by Region in 2020
Figure 21. Global Biopharma Buffer Revenue Market Share by Region (2016-2021)
Figure 22. Global Biopharma Buffer Revenue Market Share by Region in 2020
Figure 23. U.S. Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Biopharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Biopharma Buffer by Type (2016-2021)
Figure 48. Sales Market Share of Biopharma Buffer by Application (2016-2021)
Figure 49. Sales Market Share of Biopharma Buffer by Application in 2020
Figure 50. Revenue Share of Biopharma Buffer by Application (2016-2021)
Figure 51. Revenue Share of Biopharma Buffer by Application in 2020
Figure 52. Manufacturing Cost Structure of Biopharma Buffer
Figure 53. Manufacturing Process Analysis of Biopharma Buffer
Figure 54. Biopharma Buffer Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed